Degron Eyes Deals For Novel Molecular Glue Degrader Assets

$1bn+ Takeda Alliance Last Year

 
• By Dexter Jie Yan
  
Molecular glue degraders, an emerging drug class expected to unlock the therapeutic potential of historically hard-to-drug targets, have made progress by leaps and bounds over the past few years. (Shutterstock)

More from R&D

More from Interviews